Velia
Amal Lamb has a diverse work experience in various research roles. They began their career as an Intern at UC San Diego in 2015. In 2018, they joined the University of California, Davis as the Director of Advising, where they provided guidance on housing options and organized housing fairs. From 2019 to 2020, Amal worked as a Research Intern at the Genomics Institute Of The Novartis Research Foundation. They then transitioned to Calibr at Scripps Research, starting as a Research Technician and progressing to become a Research Assistant I and II. Currently, Amal is a Research Associate II at Velia.
Amal Lamb obtained a Bachelor's degree in Biology/Biological Sciences, General from the University of California, Davis. This educational journey took place between 2016 and 2020.
Velia
Velia is an emerging biotech harnessing the broad therapeutic potential of a newly identified, yet abundant class of human proteins. Transformational work from Velia founders revealed that many of those previously overlooked proteins regulate biological functions vital to human health. Velia will discover and develop therapeutics targeting these novel regulators.